Promising Results for Peanut Oral Immunotherapy

By João L. Carapinha

May 1, 2025

A real-world case series at the University of Virginia evaluated early age peanut oral immunotherapy (epOIT) in 30 children under 3 years old with peanut allergy. Of the 27 children who completed the protocol, 90% achieved daily maintenance dosing...

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.